Non-orthogonal multiple access (NOMA) is a promising technology for future beyond-5G wireless networks, whose fundamental information-theoretic limits are yet to be fully explored. Considering regular sparse code-domain NOMA (with a fixed and finite number of orthogonal resources allocated to any designated user and vice versa), this paper extends previous results by the authors to a setting comprising two classes of users with different power constraints. Explicit rigorous analytical inner and outer bounds on the achievable rate (total class throughput) region in the large-system limit are derived and comparatively investigated in extreme-SNR regimes. The inner bound is based on the conditional vector entropy power inequality (EPI), while the outer bound relies on a recent strengthened version of the EPI. Valuable insights are provided into the potential performance gains of regular sparse NOMA in practically oriented settings, comprising, e.g., a combination of low-complexity devices and broadband users with higher transmit power capabilities, or combinations of cell-edge and cell-center users. The conditions for superior performance over dense code-domain NOMA (taking the form of randomly spread code-division multiple access), as well as a relatively small gap to the ultimate performance limits, are identified. The proposed bounds are also applicable for the analysis of interference networks, e.g., Wyner-type cellular models.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871315 | PMC |
http://dx.doi.org/10.3390/e24020227 | DOI Listing |
Biom J
October 2024
Department of Biostatistics, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Cochrane Database Syst Rev
June 2024
Global Health Nursing, St. Luke's International University, Tokyo, Japan.
Rationale: Neovascular age-related macular degeneration (AMD) is a progressive eye disease characterized by choroidal neovascularization (CNV) and is a leading cause of vision loss and disability worldwide. Although intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is an effective treatment option that helps to prevent vision loss or to improve visual acuity in people with neovascular AMD, treatment imposes a significant financial burden on patients and healthcare systems. A biosimilar is a biological product that has been developed to be nearly identical to a previously approved biological product.
View Article and Find Full Text PDFThis paper proposes a high-security chaotic encrypted power sparse coding division (CE-PSCD) scheme for 7-core fiber based on non-orthogonal multiple access (NOMA) technology. The method utilizes power multiplexing to realize parallel transmission of two signals. Joint encryption of the four-dimensional region is realized using constellation mapping encryption, carrier frequency encryption, symbol scrambling, and sparse code scrambling.
View Article and Find Full Text PDFThis paper proposes a three-dimensional power sparse code division non-orthogonal multiple access (3D-PSCD-NOMA) scheme with 3D constellation pair mapping. The proposed sparse code is based on a balanced incomplete block design (BIBD). Its correlation matrix performs the overall signal mapping of multi-user information.
View Article and Find Full Text PDFStat Med
July 2023
Department of Biostatistics, Institute of Medicine, University of Tsukuba, Tennodai, Tsukuba, Japan.
Using a generalized estimating equation (GEE) can lead to a bias in regression coefficients for a small sample or sparse data. The bias-corrected GEE (BCGEE) and penalized GEE (PGEE) were proposed to resolve the small-sample bias. Moreover, the standard sandwich covariance estimator leads to a bias of standard error for small samples; several modified covariance estimators have been proposed to address this issue.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!